Arbutus Biopharma ABUS SEC Filings

NASDAQ ABUS
$5.14 +0.02 (+0.39%)
As of: Sep 4, 2026 · 2:23 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Arbutus Biopharma Corp (ABUS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index